Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AFA-281 Interaction with Alcohol in Healthy Volunteers
NCT06719908Phase 1Not yet recruiting
- Sponsor
- AfaSci, Inc.
- Start
- Jul 2025
- Primary completion
- Jul 2026
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of AFA-281 in alcohol use disorder (AUD) (4 arms), sponsored by AfaSci, Inc. Primary endpoints: Pharmacokinetic evaluation of AFA-281 at 24 hours, Evaluation of ethanol levels in the blood at 24 hours and 5 more. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
AFA-281
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT06719908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06719908.